The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic, tissue, and plasma biomarkers of outcomes from a prospective study of neoadjuvant short course proton-based chemoradiation for resectable pancreatic ductal adenocarcinoma (PDAC).
Theodore S. Hong
No relevant relationships to disclose
Vikram Deshpande
No relevant relationships to disclose
Marek Ancukiewicz
No relevant relationships to disclose
Beow Y. Yeap
No relevant relationships to disclose
Darrell R. Borger
Consultant or Advisory Role - Bio-Reference Laboratories
Jennifer Yon-Li Wo
No relevant relationships to disclose
Yves Boucher
No relevant relationships to disclose
Eunice Lee Kwak
No relevant relationships to disclose
Jeffrey W. Clark
No relevant relationships to disclose
Andrew X. Zhu
No relevant relationships to disclose
Lawrence Scott Blaszkowsky
No relevant relationships to disclose
Harvey J. Mamon
No relevant relationships to disclose
Rakesh K. Jain
No relevant relationships to disclose
David P. Ryan
No relevant relationships to disclose
Thomas F. DeLaney
No relevant relationships to disclose
Carlos Fernandez-del Castillo
No relevant relationships to disclose
Dan G. Duda
No relevant relationships to disclose